Fouad Namouni

Overview

Fouad Namouni received $7M in total compensation, including $186K in salary, at Blueprint Medicines in 2020.

Source: SEC filing on April 21, 2021.

Related executives

We found ten more executives who work or worked at Blueprint Medicines.

Jeffrey Albers

Blueprint Medicines

Chief Executive Officer

Kathryn Haviland

Blueprint Medicines

Chief Operating Officer

Tracey McCain

Blueprint Medicines

Chief Legal and Compliance Officer

Michael Landsittel

Blueprint Medicines

Chief Financial Officer

Anthony Boral

Blueprint Medicines

Chief Medical Officer

Christina Rossi

Blueprint Medicines

Chief Commercial Officer

Christopher Murray

Blueprint Medicines

Senior Vice President, Technical Operations

Kate Haviland

Blueprint Medicines

Chief Business Officer

News

You may also like